Role of anti‐domain 1‐ß2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome: reply

1 De Craemer AS, Musial J, Devreese KM. Role of anti-domain 1b2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome. J Thromb Haemost 2016; 14: 1779– 87. 2 Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derkesen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306. 3 de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE, Ruffatti A, Rozman B, Kveder T, de Moerloose P, Boehlen F, Rand J, Ulcova-Gallova Z, Mertens K, de Groot PG. The association between circulating antibodies against domain I of b2glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009; 7: 1767–73. 4 Pengo V, Ruffatti A, Tonello M, Cuffaro S, Banzato A, Bison E, Denas G, Padayattil Jose S. Antiphospholipid syndrome: antibodies to domain 1 of b2-glycoprotein 1 correctly classify patients at risk. J Thromb Haemost 2015; 13: 782–7. 5 Zhang S, Wu Z, Chen S, Li J, Wen X, Li L, Zhang W, Zhao J, Zhang F, Li Y. Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome. Sci Rep 2016; 6: 23839. 6 Mahler M, Norman GL, Meroni PL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev 2012; 12: 313–17.

[1]  H. García‐Perdomo,et al.  A meta‐analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation: comment , 2016, Journal of thrombosis and haemostasis : JTH.

[2]  J. Musial,et al.  Role of anti‐domain 1‐β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome , 2016, Journal of thrombosis and haemostasis : JTH.

[3]  Fengchun Zhang,et al.  Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome , 2016, Scientific Reports.

[4]  A. Ruffatti,et al.  Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk , 2015, Journal of thrombosis and haemostasis : JTH.

[5]  T. Ortel,et al.  Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.

[6]  K. Devreese,et al.  Differences in sensitivity of two automated assay panels for anticardiolipin and anti beta2glycoprotein I antibodies in the laboratory diagnosis of antiphospholipid syndrome due to the exposure of the domain I epitope of beta2glycoprotein I on the solid phase , 2014 .

[7]  P. D. de Groot,et al.  Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs , 2013, PloS one.

[8]  M. Khamashta,et al.  Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. , 2012, Autoimmunity reviews.

[9]  K. Devreese,et al.  Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. , 2011, Thrombosis research.

[10]  P. D. de Groot,et al.  The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study , 2009, Journal of thrombosis and haemostasis : JTH.

[11]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[12]  P. D. de Groot,et al.  IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. , 2005, Blood.